Pelikan closes $25M for handheld diagnostics

Pelikan Technologies, maker of medical devices for diagnosing and monitoring diabetes, just brought in $25 million from undiclosed investors, reports VentureWire. Based in Palo Alto, Calif., the company spun out of Agilent Technologies in 2001 with the launch of its Pelikan Sun line, an electronic lancing device used to test blood sugar.

This round of capital brings its total raised to $145 million (it last raised $89 million at the end of 2007). Past investors (that may or may not have contributed to the recent investment) include Bio*One Capital, Clarus Ventures, GE Finance, Global Life Science Ventures, HBM BioVentures, Mannheim Holdings and Oxford Finance.

Next Story: Aptera sets October delivery date for three-wheeled electric vehicle
Previous Story: Neuralitic pulls in $3M for data service analytics